KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dynavax Technologies (DVAX) Total Liabilities: 2011-2024

Historic Total Liabilities for Dynavax Technologies (DVAX) over the last 14 years, with Dec 2024 value amounting to $389.5 million.

  • Dynavax Technologies' Total Liabilities rose 8.36% to $412.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $412.4 million, marking a year-over-year increase of 8.36%. This contributed to the annual value of $389.5 million for FY2024, which is 3.85% up from last year.
  • Latest data reveals that Dynavax Technologies reported Total Liabilities of $389.5 million as of FY2024, which was up 3.85% from $375.0 million recorded in FY2023.
  • In the past 5 years, Dynavax Technologies' Total Liabilities ranged from a high of $816.9 million in FY2021 and a low of $294.6 million during FY2020.
  • For the 3-year period, Dynavax Technologies' Total Liabilities averaged around $389.8 million, with its median value being $389.5 million (2024).
  • Its Total Liabilities has fluctuated over the past 5 years, first soared by 177.30% in 2021, then slumped by 50.44% in 2022.
  • Over the past 5 years, Dynavax Technologies' Total Liabilities (Yearly) stood at $294.6 million in 2020, then soared by 177.30% to $816.9 million in 2021, then tumbled by 50.44% to $404.8 million in 2022, then decreased by 7.36% to $375.0 million in 2023, then climbed by 3.85% to $389.5 million in 2024.